Demonstrating the Value of Laboratory Medicine through Population Health

C.E. Credits: P.A.C.E. CE Florida CE
Speaker
  • Project Santa Fe Foundation Faculty
    Biography

      During her career, Ms. Swanson has worked with a wide range of professionals in health care and business to develop and facilitate new programs.  Ms. Swanson has been recognized as a leader and mentor, served on several Board of Director positions and as an elected officer for state and national groups. Ms. Swanson practiced pharmacy in a variety of environments including inpatient, outpatient, clinical, managed care, and research.  In addition to her practice experience, she has overseen local and national programs for quality management, performance improvement and measurement systems.  More recently, Ms. Swanson worked as the Director of Clinical Solutions at TriCore Reference Laboratories where she led the development and implementation of state-wide population health initiatives for high prevalence conditions in New Mexico using laboratory data. Currently she is a member of the Project Santa Fe Foundation Faculty working with multi-site groups to demonstrate the value of laboratory insights to improve patient care and reduce total costs.


    Abstract

    Clinical Laboratories have the opportunity to support value based health care by aligning with organizational strategies that focus on population health and creating meaningful insights using real time longitudinal laboratory data.  To provide diagnostic insights, laboratorians must move from providing results for a single patient, to a population focus for groups of patients.  The presentation will include examples on how data can be positioned to support the screening, diagnosis, monitoring and intervention management for groups of patients with chronic and high cost health conditions. The use of Clinical Lab 2.0 concepts to frame the development of these population based initiatives will be discussed.   Key components that will be highlighted are leadership, selecting population based initiatives, and items to consider when building an evidence base. Examples discussed will include risk stratification and identification of gaps in care. Partnerships, both inside and outside the laboratory, essential for these efforts will be described.   Partner relationships with data analytics will be covered as one of the most important components to successfully deliver insights to a variety of stakeholders including clinical providers, healthcare administrators and health plans. Measuring the success of laboratory driven population health initiatives can be challenging and complex.  This presentation will describe several measures that can be used to demonstrate value both clinically and financially.  Barriers to population health initiatives will also be included in the presentation.

    Learning Objectives:

    1. At the end of the presentation audience members will be able to identify several Clinical Lab 2.0 components that should be included when developing population health initiatives from laboratory data

    2. At the end of the presentation audience members will be able to explain the role of key partnerships both inside and outside the laboratory

    3. At the end of the presentation audience members will be able to describe at least 2 examples of how clinical laboratory data can be used to provide meaningful insights supporting population health.


    Show Resources
    You May Also Like
    SEP 10, 2020 9:00 AM PDT
    C.E. CREDITS
    SEP 10, 2020 9:00 AM PDT
    Date: September 10, 2020 Time: 9:00am (PDT), 12:00pm (EDT) Osmolality testing is relevant throughout the entire bioprocessing workflow. As customers look to refine mAb and gene therapy workf...
    NOV 18, 2020 8:00 AM PST
    C.E. CREDITS
    NOV 18, 2020 8:00 AM PST
    DATE: November 18, 2020 TIME: 08:00am PDT We develop and implement technologies to solve some of the major bottlenecks in biomedical research. In particular, we establish new imaging approac...
    AUG 25, 2020 8:00 AM PDT
    C.E. CREDITS
    AUG 25, 2020 8:00 AM PDT
    DATE: August 25, 2020 TIME: 8:00am PDT, 10:00am CDT, 11:00am EDT Recombinant lentivirus (LV) and adeno-associated virus (AAV) are critical components of cell and gene therapies, which show g...
    DEC 15, 2020 10:00 AM PST
    C.E. CREDITS
    DEC 15, 2020 10:00 AM PST
    DATE: December 15, 2020 TIME: 10:00am PST Scientists from Thermo Fisher Scientific will walk us through the world of microorganisms. They will discuss their most recent research on viruses,...
    NOV 16, 2020 8:00 AM PST
    C.E. CREDITS
    NOV 16, 2020 8:00 AM PST
    Date: November 16, 2020 Time: 8:00am (PST), 11:00am (EST) CRISPR screening has become the prime discovery tool in modern biomedical research and drug discovery. At the same time, most screen...
    OCT 29, 2020 6:00 AM PDT
    C.E. CREDITS
    OCT 29, 2020 6:00 AM PDT
    Date: October 29, 2020 Time: 6:00am (PDT), 9:00am (EDT), Chronic inflammation can occur as a result of a combination of genetic predispositions and environmental factors. Epigenetic modifica...
    Loading Comments...
    Show Resources